Chemours Co: Form 10-Q for the period ended Jun 30, 2022
Filed with the SEC on Aug 1, 2022 and accepted by EDGAR at Jul 29, 2022, 17:52 ET.
Management's discussion and analysis
As filed, 96,748 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) supplements the unaudited Interim Consolidated Financial Statements and the related notes thereto included elsewhere herein to help provide an understanding of our financial condition, changes in our financial condition, and the results of our operations for the periods presented. Unless the context otherwise requires, references herein to “The Chemours Company”, “Chemours”, “the Company”, “our Company”, “we”, “us”, and “our” refer to The Chemours Company and its consolidated subsidiaries. References herein to “EID” refer to E. I. du Pont de Nemours and Company, which is our former parent company and is now a subsidiary of Corteva, Inc. (“Corteva”), a Delaware corporation, unless the context otherwise requires. References herein to “DuPont” refer to DuPont de Nemours, Inc., a Delaware Corporation.
This MD&A should be read in conjunction with the unaudited Interim Consolidated Financial Statements and the related notes thereto included in Item 1 of this Quarterly Report on Form 10-Q, as well as our audited Consolidated Financial Statements and the related notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2021.
This section and other parts of this Quarterly Report on Form 10-Q contain forward-looking statements, within the meaning of the federal securities laws, that involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. The words “believe”, “expect”, “anticipate”, “plan”, “estimate”, “target”, “project”, and similar expressions, among others, generally identify “forward-looking statements”, which speak only as of the date the statements were made. The matters discussed in these forward-looking statements are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those set forth in the forward-looking statements.
Our forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized. These statements, as well as our historical performance, are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond our control. Additionally, there may be other risks and uncertainties that we are unable to identify at this time or that we do not currently expect to have a material impact on our business. Factors that could cause or contribute to these differences include, but are not limited to, the risks, uncertainties, and other factors discussed in the Forward-looking Statements and the Risk Factors sections in our Annual Report on Form 10-K for the year ended December 31, 2021, and as otherwise discussed in this report. We assume no obligation to revise or update any forward-looking statement for any reason, except as required by law.
Overview
We are a leading, global provider of performance chemicals that are key inputs in end-products and processes in a variety of industries. We deliver customized solutions with a wide range of industrial and specialty chemical products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, general industrial, and oil and gas. Our principal products include titanium dioxide (“TiO2”) pigment, refrigerants, industrial fluoropolymer resins, and performance chemicals and intermediates. We manage and report our operating results through three reportable segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. Our Titanium Technologies segment is a leading, global provider of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, and protection in a variety of applications. Our Thermal & Specialized Solutions segment is a leading, global provider of refrigerants, thermal management solutions, propellants, blowing agents, and specialty solvents. Our Advanced Performance Materials segment is a leading, global provider of high-end polymers and advanced materials that deliver unique attributes, including low friction coefficients, extreme temperature resistance, weather resistance, ultraviolet and chemical resistance, and electrical insulation. Our Performance Chemicals and Intermediates business and our Mining Solutions business (prior to the business sale in 2021) are presented under Other Segment.
We are a different kind of chemistry company, driven by our vision to create a better world through the power of our chemistry. Our world-class product portfolio brings everyday convenience to virtually everything people touch in their daily lives, making our products and the solutions they enable both vital and essential. We are committed to creating value for our customers and stakeholders around the world through innovative and sustainable solutions, environmental leadership, community impact and making Chemours the greatest place to work for every employee. Our global workforce, renowned for its deep and unmatched expertise, bring our chemistry to life, guided by five core values that form the bedrock foundation for how we operate: (i) Customer Centricity – driving customer growth, and our own, by understanding our customers’ needs and building long-lasting relationships with them; (ii) Refreshing Simplicity – cutting complexity by investing in what matters, and getting results faster; (iii) Collective Entrepreneurship – empowering our employees to act like they own our business, while embracing the power of inclusion and teamwork; (iv) Safety Obsession – living our steadfast belief that a safe workplace is a profitable workplace; and, (v) Unshakable Integrity – doing what’s right for our customers, colleagues, and communities – always.
Additionally, our Corporate Responsibility Commitment focuses on three key principles – inspired people, a shared planet, and an evolved portfolio – in an effort to achieve, among other goals, increased diversity and inclusion in our global workforce, increased sustainability of our products, and addressing our carbon emissions. We call this responsible chemistry – it is rooted in who we are, and we expect that our Corporate Responsibility Commitment will drive sustainable, long-term earnings growth.
Recent Developments
Russia-Ukraine Conflict
In response to the ongoing conflict between Russia and Ukraine, there have been targeted economic sanctions on Russia, and in March 2022 we announced suspension of our business with Russian entities. While neither Russia nor Ukraine has composed or is expected to compose a material portion of Chemours’s total consolidated revenues, further escalation of geopolitical tensions could have a broader impact that expands into other geographical regions where we do business, which could adversely impact the economic activity in those regions and cause broader disruption of global supply chains. Potential impacts from further escalation of this rapidly evolving situation are currently unknown and could potentially subject our business to materially adverse consequences should the situation escalate beyond its current scope. The risks and uncertainties around operating as a multi-national corporation, include, but are not limited to, those described in Item 1A - Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2021.
Results of Operations and Business Highlights
Results of Operations
The following table sets forth our results of operations for the three and six months ended June 30, 2022 and 2021.
(Dollars in millions, except per share amounts)
| Three Months Ended June 30, 2022 | 2021 | Six Months Ended June 30, 2022 | 2021 | |
|---|---|---|---|---|
| Net sales | $1,915 | $1,655 | $3,679 | $3,091 |
| Cost of goods sold | 1,418 | 1,391 | 2,697 | 2,530 |
| Gross profit | 497 | 264 | 982 | 561 |
| Selling, general, and administrative expense | 254 | 172 | 395 | 310 |
| Research and development expense | 25 | 27 | 55 | 51 |
| Restructuring, asset-related, and other charges | 1 | 5 | 12 | — |
| Total other operating expenses | 280 | 204 | 462 | 361 |
| Equity in earnings of affiliates | 16 | 10 | 28 | 20 |
| Interest expense, net | (40) | (47) | (82) | (97) |
| Other income, net | 38 | 21 | 44 | 21 |
| Income before income taxes | 231 | 44 | 510 | 144 |
| Provision for (benefit from) income taxes | 30 | (22) | 76 | (17) |
| Net income | 201 | 66 | 434 | 161 |
| Net income attributable to Chemours | $201 | $66 | $434 | $161 |
| Per share data | ||||
| Basic earnings per share of common stock | $1.29 | $0.40 | $2.75 | $0.97 |
| Diluted earnings per share of common stock | 1.26 | 0.39 | 2.69 | 0.95 |
49
Net Sales
The following table sets forth the impacts of price, volume, currency, and portfolio changes on our net sales for the three and six months ended June 30, 2022, compared with the same periods in 2021.
| Change in net sales from prior period | Three Months Ended June 30, 2022 | Six Months Ended June 30, 2022 |
|---|---|---|
| Price | 23% | 24% |
| Volume | (1)% | 1% |
| Currency | (2)% | (2)% |
| Portfolio | (4)% | (4)% |
| Total change in net sales | 16% | 19% |
Our net sales increased by $260 million (or 16%) to $1.9 billion for the three months ended June 30, 2022, compared with net sales of $1.7 billion for the same period in 2021. The increase in our net sales for the three months ended June 30, 2022 was primarily attributable to an increase in price of 23%, partially offset by a decrease in volume of 1% and portfolio change of 4% driven by the sale of our Mining Solutions business in 2021. Price increased across all our reportable segments, while volume decreases were largely contributed by our Titanium Technologies segment, substantially offset by higher volume in our Thermal and Specialized Solutions segment. Unfavorable currency movements in all our reportable segments added a headwind of 2% to our net sales.
Our net sales increased by $588 million (or 19%) to $3.7 billion for the six months ended June 30, 2022, compared with net sales of $3.1 billion for the same period in 2021. The increase in our net sales for the six months ended June 30, 2022 was primarily attributable to an increase in price of 24% and an increase in volume of 1%, partially offset by portfolio change of 4% driven by the sale of our Mining Solutions business in 2021. Price increased across all our reportable segments and volume increased in our Thermal & Specialized Solutions and Advanced Performance Materials segments. Unfavorable currency movements in all our reportable segments added a headwind of 2% to our net sales.
The key drivers of these changes for each of our segments are discussed further under the “Segment Reviews” section within this MD&A.
Cost of Goods Sold
Our cost of goods sold (“COGS”) increased by $27 million (or 2%) and $167 million (or 7%) to $1.4 billion and $2.7 billion for the three and six months ended June 30, 2022, respectively, compared with COGS of $1.4 billion and $2.5 billion for the same periods in 2021. The increases in our COGS for the three and six months ended June 30, 2022 were primarily attributable to higher net sales, higher raw material costs due to inflation and supply constraints, higher distribution, freight, and logistics expenses, partially offset by higher on-site remediation costs at our Fayetteville Works site in Fayetteville, North Carolina (“Fayetteville”) during 2021 and Qualified Spend recovery from DuPont and Corteva recognized in the first and second quarter of 2022 (none recognized comparatively in the same period of 2021).
Selling, General, and Administrative Expense
Our selling, general, and administrative (“SG&A”) expense increased by $82 million (or 48%) and $85 million (or 27%) to $254 million and $395 million for the three and six months ended June 30, 2022, respectively, compared with SG&A expense of $172 million and $310 million for the same periods in 2021. The increases in our SG&A expense for the three and six months ended June 30, 2022 were primarily attributable to increased off-site environmental remediation costs at Fayetteville in 2022 of approximately $108 million, partially offset by the $25 million charge incurred in the second quarter of 2021 in connection with our portion of the settlement agreement with the State of Delaware.
Research and Development Expense
Our research and development (“R&D”) expense was largely unchanged at $25 million for the three months ended June 30, 2022, compared with R&D expense of $27 million for the same period in 2021. Our R&D expense increased by $4 million (or 8%) to $55 million for the six months ended June 30, 2022, compared with R&D expense of $51 million for the same period in 2021. The increase in our R&D expense for the six months ended June 30, 2022 was primarily attributable to growth initiatives in the current year and our increased focus on product development in our Advanced Performance Materials segment.
Restructuring, Asset-Related, and Other Charges
Our restructuring, asset-related, and other charges decreased by $4 million (or 80%) to $1 million for the three months ended June 30, 2022, compared with restructuring, asset-related, and other charges of $5 million for the same period in 2021. Our restructuring, asset-related, and other charges increased by $12 million (or 100%) to $12 million for the six months ended June 30, 2022, compared with restructuring, asset-related, and other charges of less than $1 million for the same period in 2021. The $12 million increase in our restructuring, asset-related, and other charges for the six months ended June 30, 2022 was primarily attributable to $5 million of asset charges resulting from the conflict between Russia and Ukraine and our decision to suspend business with Russian entities, and $6 million of employee separation charges incurred in connection with our 2022 Restructuring Program.
Our restructuring, asset-related, and other charges for the three and six months ended June 30, 2021 were primarily attributable to $4 million and $8 million of decommissioning and dismantling related charges in connection with our decision to exit the Aniline business and stop production at our Pascagoula, Mississippi manufacturing plants. For the six months ended June 30, 2021 the decrease was offset by a net $7 million gain in Other Charges in connection with our contract termination with a third-party services provider at our previously owned Mining Solutions facility in Gomez Palacio, Durango, Mexico.
Equity in Earnings of Affiliates
Our equity in earnings of affiliates increased by $6 million (or 60%) and $8 million (or 40%) to $16 million and $28 million for the three and six months ended June 30, 2022, respectively, compared with equity in earnings of affiliates of $10 million and $20 million for the same periods in 2021. The increases in our equity in earnings of affiliates for the three and six months ended June 30, 2022 were primarily attributable to increased pricing and demand for our investees’ products.
Interest Expense, Net
Our interest expense, net decreased by $7 million (or 15%) and $15 million (or 15%) to $40 million and $82 million for the three and six months ended June 30, 2022, respectively, compared with interest expense, net of $47 million and $97 million for the same periods in 2021. The decreases in our interest expense, net for the three and six months ended June 30, 2022 were primarily attributable to a reduction in our outstanding debt obligations and associated rates following the refinancing of our 7.000% senior notes due May 2025, denominated in U.S. dollars, in August of 2021.
Other Income, Net
Our other income, net increased by $17 million (or 81%) and $23 million (or over 100%) to $38 million and $44 million for the three and six months ended June 30, 2022, respectively, compared with other income, net of $21 million for the same periods in 2021. The increases in our other income, net for the three and six months ended June 30, 2022 were primarily attributable to a net pre-tax gain on sale of $11 million and $18 million associated with the sale of our land related to the Beaumont former operating site (the “Beaumont Transaction”) and the stock sale of certain of our wholly-owned subsidiaries and the remaining assets at our former Aniline business facilities in Pascagoula, Mississippi (the “Pascagoula Transaction”), respectively. For the three months ended June 30, 2022, the comparative increase in our other income, net was partially offset by unfavorable changes in net exchange gains and losses of $6 million.
Provision for (Benefit from) Income Taxes
We have a provision for income taxes of $30 million for the three months ended June 30, 2022 and a benefit from income taxes of $22 million for the three months ended June 30, 2021, which represented effective tax rates of 13% and negative 50%, respectively. The $52 million increase in our provision for income taxes for the three months ended June 30, 2022 was attributable to increased profitability, changes to our geographical mix of earnings, and changes to non-recurring items. Changes to non-recurring items include a tax expense of $6 million associated with the Beaumont and Pascagoula Transactions recognized in the pre-tax gain on sale during the second quarter of 2022 and an $11 million income tax benefit recognized in the second quarter of 2021 associated with a 2012 income tax refund received in a foreign subsidiary.
We have a provision for income taxes of $76 million for the six months ended June 30, 2022 and a benefit from income taxes of $17 million for the six months ended June 30, 2021, which represented effective tax rates of 15% and negative 12%, respectively. The $93 million increase in our provision for income taxes for the six months ended June 30, 2022, respectively, was primarily attributable to the same factors discussed in the preceding paragraph regarding increases for the three months ended June 30, 2022 and 2021.
Segment Reviews
Beginning with reports filed in the first quarter of 2022, we changed our methodology used to allocate certain corporate function expenses to our operating segments to provide our Chief Operating Decision Maker (“CODM”) with a more meaningful representation of segment profitability. This allocation methodology change reflects corporate function resource usage by each operating segment based on certain commercial drivers, in addition to the cost drivers, as well as consideration of our recent sale of the Mining Solutions business in 2021. The historical segment information, including adjusted earnings before interest, taxes, depreciation, and amortization (“Adjusted EBITDA”), has been recast to conform to the current segment presentation.
Adjusted EBITDA is the primary measure of segment profitability used by our CODM and is defined as income (loss) before income taxes, excluding the following:
- interest expense, depreciation, and amortization;
- non-operating pension and other post-retirement employee benefit costs, which represents the component of net periodic pension (income) costs excluding the service cost component;
- exchange (gains) losses included in other income (expense), net;
- restructuring, asset-related, and other charges;
- (gains) losses on sales of assets and businesses; and,
- other items not considered indicative of our ongoing operational performance and expected to occur infrequently, including Qualified Spend reimbursable by DuPont and/or Corteva as part of our cost-sharing agreement under the terms of the Memorandum of Understanding (“MOU”) that were previously excluded from Adjusted EBITDA.
A reconciliation of net income (loss) attributable to Chemours to Adjusted EBITDA for the three and six months ended June 30, 2022 and 2021 is included in the “Non-GAAP Financial Measures” section of this MD&A.
The following table sets forth our Adjusted EBITDA by segment for the three and six months ended June 30, 2022 and 2021.
(Dollars in millions)
| Three Months Ended June 30, 2022 | 2021 | Six Months Ended June 30, 2022 | 2021 | |
|---|---|---|---|---|
| Titanium Technologies | $216 | $217 | $422 | $383 |
| Thermal & Specialized Solutions | 213 | 115 | 387 | 205 |
| Advanced Performance Materials | 107 | 79 | 194 | 137 |
| Other Segment | (2) | 18 | (2) | 27 |
| Corporate and Other | (59) | (63) | (123) | (118) |
| Total Adjusted EBITDA | $475 | $366 | $878 | $634 |
52
Titanium Technologies
The following table sets forth the net sales, Adjusted EBITDA, and Adjusted EBITDA margin amounts for our Titanium Technologies segment for the three and six months ended June 30, 2022 and 2021.
(Dollars in millions)
| Three Months Ended June 30, 2022 | 2021 | Six Months Ended June 30, 2022 | 2021 | |
|---|---|---|---|---|
| Segment net sales | $968 | $859 | $1,897 | $1,583 |
| Adjusted EBITDA | 216 | 217 | 422 | 383 |
| Adjusted EBITDA margin | 22% | 25% | 22% | 24% |
The following table sets forth the impacts of price, volume, currency, and portfolio changes on our Titanium Technologies segment’s net sales for the three and six months ended June 30, 2022, compared with the same periods in 2021.
| Change in segment net sales from prior period | Three Months Ended June 30, 2022 | Six Months Ended June 30, 2022 |
|---|---|---|
| Price | 23% | 23% |
| Volume | (8)% | (1)% |
| Currency | (2)% | (2)% |
| Portfolio | —% | —% |
| Total change in segment net sales | 13% | 20% |
Segment Net Sales
Our Titanium Technologies segment’s net sales increased by $109 million (or 13%) and $314 million (or 20%) to $968 million and $1.9 billion for the three and six months ended June 30, 2022, respectively, compared with segment net sales of $859 million and $1.6 billion for the same period in 2021. The increase in segment net sales for the three and six months ended June 30, 2022 was primarily attributable to an increase in price of 23% for both periods, partially offset by a decrease in volume of 8% and 1%, respectively. Price increases were due to contractual price changes, as well as price increases in our Flex and Distribution channels. Volume decreases were driven by constraints in output due to ore shortages, despite a steady demand for our products across all end-markets and regions. Unfavorable currency movements added a 2% headwind to the segment’s net sales during both the three and six months ended June 30, 2022.
Adjusted EBITDA and Adjusted EBITDA Margin
For the three months ended June 30, 2022, segment Adjusted EBITDA remained largely unchanged at $216 million and Adjusted EBITDA margin decreased by approximately 300 basis points to 22%, compared with segment Adjusted EBITDA of $217 million and Adjusted EBITDA margin of 25% for the same period in 2021. For the six months ended June 30, 2022, segment Adjusted EBITDA increased by $39 million (or 10%) to $422 million and Adjusted EBITDA margin decreased by approximately 200 basis points to 22%, compared with segment Adjusted EBITDA of $383 million and Adjusted EBITDA margin of 24% for the same period in 2021. Adjusted EBITDA for the three months ended June 30, 2022 remained largely unchanged as the impact of lower volumes and higher raw material, energy and logistics costs was largely offset by the aforementioned increase in price. The increase in Adjusted EBITDA during the six months ended June 30, 2022 was primarily attributable to the aforementioned increase in price, partially offset by higher raw material, energy and logistics costs. The decreases in Adjusted EBITDA margin during the three and six months ended June 30, 2022 were primarily attributable to the aforementioned higher raw material, energy, and logistics costs.
Thermal & Specialized Solutions
The following table sets forth the net sales, Adjusted EBITDA, and Adjusted EBITDA margin amounts for our Thermal & Specialized Solutions segment for the three and six months ended June 30, 2022 and 2021.
(Dollars in millions)
| Three Months Ended June 30, 2022 | 2021 | Six Months Ended June 30, 2022 | 2021 | |
|---|---|---|---|---|
| Segment net sales | $518 | $340 | $943 | $643 |
| Adjusted EBITDA | 213 | 115 | 387 | 205 |
| Adjusted EBITDA margin | 41% | 34% | 41% | 32% |
The following table sets forth the impacts of price, volume, currency, and portfolio changes on our Thermal & Specialized Solutions segment’s net sales for the three and six months ended June 30, 2022, compared with the same periods in 2021.
| Change in segment net sales from prior period | Three Months Ended June 30, 2022 | Six Months Ended June 30, 2022 |
|---|---|---|
| Price | 39% | 40% |
| Volume | 15% | 8% |
| Currency | (2)% | (1)% |
| Portfolio | —% | —% |
| Total change in segment net sales | 52% | 47% |
Segment Net Sales
Our Thermal & Specialized Solutions segment’s net sales increased by $178 million (or 52%) and $300 million (or 47%) to $518 million and $943 million for the three and six months ended June 30, 2022, respectively, compared with segment net sales of $340 million and $643 million for the same period in 2021. The increase in segment net sales for the three and six months ended June 30, 2022 was primarily attributable to an increase in price of 39% and 40%, respectively, and an increase in volume of 15% and 8%, respectively. Prices increased in most markets across the business due to changing market and regulatory dynamics and measures taken to recover increases in cost of raw materials. Volumes increased due to continued adoption of OpteonTM and other specialized solutions. Unfavorable currency movements added a 2% and 1% headwind to the segment’s net sales during the three and six months ended June 30, 2022, respectively.
Adjusted EBITDA and Adjusted EBITDA Margin
For the three months ended June 30, 2022, segment Adjusted EBITDA increased by $98 million (or 85%) to $213 million and Adjusted EBITDA margin increased by approximately 700 basis points to 41%, compared with segment Adjusted EBITDA of $115 million and Adjusted EBITDA margin of 34% for the same period in 2021. For the six months ended June 30, 2022, segment Adjusted EBITDA increased by $182 million (or 89%) to $387 million and Adjusted EBITDA margin increased by approximately 900 basis points to 41%, compared with segment Adjusted EBITDA of $205 million and Adjusted EBITDA margin of 32% for the same period in 2021. The increases in segment Adjusted EBITDA and Adjusted EBITDA margin for the three and six months ended June 30, 2022 were primarily attributable to the aforementioned increase in price and favorable product mix, partially offset by higher raw material costs.
Advanced Performance Materials
The following table sets forth the net sales, Adjusted EBITDA, and Adjusted EBITDA margin amounts for our Advanced Performance Materials segment for the three and six months ended June 30, 2022 and 2021.
(Dollars in millions)
| Three Months Ended June 30, 2022 | 2021 | Six Months Ended June 30, 2022 | 2021 | |
|---|---|---|---|---|
| Segment net sales | $401 | $362 | $786 | $695 |
| Adjusted EBITDA | 107 | 79 | 194 | 137 |
| Adjusted EBITDA margin | 27% | 22% | 25% | 20% |
The following table sets forth the impacts of price, volume, currency, and portfolio changes on our Advanced Performance Materials segment’s net sales for the three and six months ended June 30, 2022, compared with the same periods in 2021.
| Change in segment net sales from prior period | Three Months Ended June 30, 2022 | Six Months Ended June 30, 2022 |
|---|---|---|
| Price | 15% | 15% |
| Volume | (1)% | 1% |
| Currency | (3)% | (3)% |
| Portfolio | —% | —% |
| Total change in segment net sales | 11% | 13% |
Segment Net Sales
Our Advanced Performance Materials segment’s net sales increased by $39 million (or 11%) to $401 million for the three months ended June 30, 2022, compared with segment net sales of $362 million for the same period in 2021. The increase in segment net sales for the three months ended June 30, 2022 was primarily attributable to an increase in price of 15%, partially offset by a decrease in volume of 1%. Global average selling price increased due to increasing sales in high-value end-markets, including advanced electronics, semiconductors, and clean energy, as well as customer level pricing actions to offset increased raw material and energy costs. Volume decreased slightly due to lower demand in non-strategic end-markets where fade has been anticipated given our strategy to drive higher value, differentiated product offerings. Unfavorable currency movements added a 3% headwind to the segment’s net sales during the three months ended June 30, 2022.
Our Advanced Performance Materials segment’s net sales increased by $91 million (or 13%) to $786 million for the six months ended June 30, 2022, respectively, compared with segment net sales of $695 million for the same period in 2021. The increase in segment net sales for the six months ended June 30, 2022 was primarily attributable to increases in price of 15% and volume of 1%. Global average selling price increased due to increasing sales in high-value end-markets, including advanced electronics, semiconductors, and clean energy, as well as customer level pricing actions to offset increased raw material and energy costs. Volume increased due to higher global customer demand across nearly all regions and markets, partially offset by supply chain challenges and lower demand in non-strategic end-markets where fade has been anticipated given our strategy to drive higher value, differentiated product offerings. Unfavorable currency movements added a 3% headwind to the segment’s net sales during the six months ended June 30, 2022.
Adjusted EBITDA and Adjusted EBITDA Margin
For the three months ended June 30, 2022, segment Adjusted EBITDA increased by $28 million (or 35%) to $107 million and Adjusted EBITDA margin increased by approximately 500 basis points to 27%, compared with segment Adjusted EBITDA of $79 million and Adjusted EBITDA margin of 22% for the same period in 2021. For the six months ended June 30, 2022, segment Adjusted EBITDA increased by $57 million (or 42%) to $194 million and Adjusted EBITDA margin increased by approximately 500 basis points to 25%, compared with segment Adjusted EBITDA of $137 million and Adjusted EBITDA margin of 20% for the same period in 2021. The increases in segment Adjusted EBITDA and Adjusted EBITDA margin for the three and six months ended June 30, 2022 were primarily attributable to the aforementioned favorable mix and increase in price, partially offset by higher raw material, energy, and logistics costs and growth investments.
Corporate and Other
Corporate and Other costs decreased by $4 million (or 6%) and increased by $5 million (or 4%) to $59 million and $123 million for the three and six months ended June 30, 2022, respectively, compared with Corporate and Other costs of $63 million and $118 million for the same periods in 2021. The decrease in Corporate and Other costs for the three months ended June 30, 2022 was primarily attributable to lower legacy legal costs and Qualified Spend recovery recognized in 2022 (none recognized in 2021), partially offset by regulatory and environmental-related costs. The increase in Corporate and Other costs for the six months ended June 30, 2022 was primarily attributable to higher costs associated with regulatory and environmental costs and initiatives, partially offset by lower legacy legal costs and Qualified Spend recovery from DuPont and Corteva recognized in the first half of 2022 (none recognized in the first half of 2021).
2022 Outlook
Our 2022 results will be driven by the following expectations in each of our reportable segments:
- **Titanium Technologies –**Continued demand strength across most end-markets with demand normalizing to long-term global GDP rates, partially offset by headwinds from raw material inflation and shortages, logistics challenges, and customer supply chain issues;
- Thermal & Specialized Solutions – Improved customer demand for our refrigerants, including continued OpteonTM adoption in mobile and stationary applications, paired with market recovery from semiconductor supply chain constraints; and,
- Advanced Performance Materials – Continued strong demand for our polymers across diverse end-markets, partially offset by raw material inflation, energy costs, and logistics challenges.
We expect that our capital expenditures will be approximately $400 million.
Our outlook for 2022 reflects our current visibility and expectations based on market factors, such as currency movements, macro-economic factors, and end-market demand. In particular, macro-economic factors may be impacted by factors beyond our control, including the ongoing Russia-Ukraine conflict. Our ability to meet our expectations are subject to numerous risks, including, but not limited to, those described in Item 1A – Risk Factors within our Annual Report on Form 10-K for the year ended December 31, 2021.
Liquidity and Capital Resources
Our primary sources of liquidity are cash generated from operations and available cash, along with our receivables securitization and borrowings under our debt financing arrangements, both of which are described in further detail in “Note 14 – Debt” to the Interim Consolidated Financial Statements and “Note 20 – Debt” to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2021. Our operating cash flow generation is driven by, among other things, the general global economic conditions at any point in time and their resulting impacts on demand for our products, raw materials and energy prices, and industry-specific issues, such as production capacity and utilization. We have generated strong operating cash flows through various past industry and economic cycles, evidencing the underlying operating strength of our businesses.
At June 30, 2022, we had total cash and cash equivalents of $1.2 billion, of which $644 million was held by our foreign subsidiaries. All cash and cash equivalents held by our foreign subsidiaries is readily convertible into currencies used in our operations, including the U.S. dollar. During the six months ended June 30, 2022, we received approximately $366 million of net cash in the U.S. through dividends. Management believes that sufficient liquidity is available in the U.S. through at least July 2023, which includes borrowing capacity under our revolving credit facility. For further information related to our income tax positions, refer to “Note 9 – Income Taxes” to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2021.
Over the course of the next 12 months and beyond, we anticipate making significant cash payments for known contractual and other obligations, which we expect to fund through cash generated from operations, available cash, receivables securitization, and our existing debt financing arrangements. Such obligations include principal and interest obligations on long-term debt, contractual obligations for operating and finance leases, purchase obligations, and our expectations for capital expenditures, which did not significantly change from what was previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2021. Our contractual and other obligations also include:
- Environmental remediation – We, due to the terms of our Separation-related agreements with EID, are subject to contingencies pursuant to environmental laws and regulations that in the future may require further action to correct the effects on the environment of prior disposal practices or releases of chemical substances, which are attributable to EID’s activities before our spin-off. Much of this liability results from Comprehensive Environmental Response Compensation and Liability Act (“CERCLA”), Resource Conservation and Recovery Act (“RCRA”), and similar federal, state, local, and foreign laws. These laws may require us to undertake certain investigative, remediation, and restoration activities at sites where we conduct or EID once conducted operations or at sites where waste generated by us was disposed. At June 30, 2022, our consolidated balance sheets include $707 million for environmental remediation liabilities, of which $239 million was classified as current, and a portion is subject to recovery under the MOU. Of the current environmental liabilities of $239 million, $181 million relates to Fayetteville. Pursuant to the binding MOU that we entered into with DuPont, Corteva, and EID in January 2021, costs related to potential future legacy PFAS liabilities arising out of pre-July 1, 2015 conduct will be subject to the cost-sharing arrangement, where we bear half of the cost of such future potential legacy PFAS liabilities, and DuPont and Corteva will collectively bear the other half of the cost of such future potential legacy PFAS liabilities. Refer to the “Environmental Matters” section within this MD&A for the anticipated environmental remediation payments over the next three years. Refer to “Note 16 – Commitments and Contingent Liabilities” to the Interim Consolidated Financial Statements for further discussion of the MOU and Qualified Spend.
- PFAS escrow funding requirements – Pursuant to the binding MOU that we entered into with DuPont, Corteva, and EID in January 2021, the next escrow payment of $100 million is expected to be made on or before September 30, 2022. Refer to “Note 16 – Commitments and Contingent Liabilities” to the Interim Consolidated Financial Statements for further discussion.
We continue to believe our sources of liquidity are sufficient to fund our planned operations and to meet our interest, dividend, and contractual obligations through at least July 2023. Our financial policy seeks to: (i) selectively invest in organic and inorganic growth to enhance our portfolio, including certain strategic capital investments; (ii) maintain appropriate leverage by using free cash flows to repay outstanding borrowings; and, (iii) return cash to shareholders through dividends and share repurchases. Specific to our objective to return cash to shareholders, in recent quarters, we have previously announced dividends of $0.25 per share, amounting to approximately $160 million per year, and, on July 27, 2022, we announced our quarterly cash dividend of $0.25 per share for the third quarter of 2022. Under our share repurchase program, as further discussed in Item 2 –Unregistered Sales of Equity Securities and Use of Proceeds in this Quarterly Report on Form 10-Q, we also have remaining authority to repurchase $731 million of our outstanding common stock. Subject to approval by our board of directors, we may raise additional capital or borrowings from time to time, or seek to refinance our existing debt. There can be no assurances that future capital or borrowings will be available to us, and the cost and availability of new capital or borrowings could be materially impacted by market conditions. Further, the decision to refinance our existing debt is based on a number of factors, including general market conditions and our ability to refinance on attractive terms at any given point in time. Any attempts to raise additional capital or borrowings or refinance our existing debt could cause us to incur significant charges. Such charges could have a material impact on our financial position, results of operations, or cash flows.
Cash Flows
The following table sets forth a summary of the net cash provided by (used for) our operating, investing, and financing activities for the six months ended June 30, 2022 and 2021.
(Dollars in millions)
| Six Months Ended June 30, 2022 | 2021 | |
|---|---|---|
| Cash provided by operating activities | $293 | $295 |
| Cash used for investing activities | (145) | (134) |
| Cash used for financing activities | (320) | (118) |
Operating Activities
We generated $293 million and $295 million in cash flows from our operating activities during the six months ended June 30, 2022 and 2021, respectively. The slight decrease in our operating cash inflows was primarily attributable to working capital build-up, primarily in receivables, and payment of the $25 million settlement with the State of Delaware. This was partially offset by a decrease in our accounts payable, which was driven by the timing of payments to our vendors.
Investing Activities
We used $145 million and $134 million in cash flows for our investing activities during the six months ended June 30, 2022 and 2021, respectively which were primarily attributable to purchases of property, plant, and equipment amounting to $168 million and $127 million, respectively, partially offset by $17 million of cash proceeds related to the Beaumont Transaction and $16 million of cash proceeds related to the Pascagoula Transaction during the six months ended June 30, 2022. Purchases of property, plant, and equipment for the six months ended June 30, 2021 included $22 million of assets acquired in exchange for the termination of a contract with a third-party service provider at our previously owned Mining Solutions facility in Gomez Palacio, Durango, Mexico.
Financing Activities
We used $320 million in cash flows for our financing activities during the six months ended June 30, 2022 which were primarily attributable to our capital allocation activities, resulting in $272 million in purchases of our issued and outstanding common stock under our 2022 Share Repurchase Program and our 2018 Share Repurchase Program and $78 million returned to our shareholders in the form of cash dividends, partially offset by $48 million in stock option exercises.
We used $118 million in cash flows for our financing activities during the six months ended June 30, 2021 which were primarily attributable to $27 million in debt repayments and return to our shareholders in the form of share repurchases of $13 million, and cash dividends of $82 million.
Current Assets
The following table sets forth the components of our current assets at June 30, 2022 and December 31, 2021.
(Dollars in millions)
| June 30, 2022 | December 31, 2021 | |
|---|---|---|
| Cash and cash equivalents | $1,248 | $1,451 |
| Accounts and notes receivable, net | 1,066 | 720 |
| Inventories | 1,219 | 1,099 |
| Prepaid expenses and other | 73 | 75 |
| Total current assets | $3,606 | $3,345 |
Our accounts and notes receivable, net increased by $346 million (or 48%) to $1.1 billion at June 30, 2022, compared with accounts and notes receivable, net of $720 million at December 31, 2021. This increase in our accounts and notes receivable, net at June 30, 2022 was primarily attributable to higher net sales, the timing of collections from our customers, and an increase in receivables under the transition services agreement with Draslovka Holding a.s. associated with the sale of our Mining Solutions business.
Our inventories increased by $120 million (or 11%) to $1.2 billion at June 30, 2022, compared with inventories of $1.1 billion at December 31, 2021. The increase in our inventories at June 30, 2022 was primarily attributable to build-up of our finished product inventories, along with higher raw material costs.
Current Liabilities
The following table sets forth the components of our current liabilities at June 30, 2022 and December 31, 2021.
(Dollars in millions)
| June 30, 2022 | December 31, 2021 | |
|---|---|---|
| Accounts payable | $1,249 | $1,162 |
| Compensation and other employee-related costs | 111 | 173 |
| Short-term and current maturities of long-term debt | 24 | 25 |
| Current environmental remediation | 239 | 173 |
| Other accrued liabilities | 263 | 325 |
| Total current liabilities | $1,886 | $1,858 |
Our accounts payable increased by $87 million (or 7%) to $1.2 billion at June 30, 2022 compared with accounts payable of $1.2 billion at December 31, 2021. The increase in our accounts payable was primarily attributable to higher raw materials purchases in connection with higher sales volumes and the timing of payments to our vendors.
Our compensation and other employee-related costs decreased by $62 million (or 36%) to $111 million at June 30, 2022 compared with compensation and other employee-related costs of $173 million at December 31, 2021. The decrease in our compensation and other employee-related costs at June 30, 2022 was primarily attributable to decreased accruals for employee performance-based compensation following payout of 2021 employee performance-based compensation during the first quarter of 2022.
Our current environmental remediation increased by $66 million (or 38%) to $239 million at June 30, 2022 compared with current environmental remediation of $173 million at December 31, 2021. The increase in our current environmental remediation at June 30, 2022 was primarily attributable to increased accruals for construction of the barrier wall at Fayetteville, as well as off-site groundwater testing and water treatment system installations at qualifying third-party properties primarily in Bladen and Cumberland counties surrounding Fayetteville and for the assessment and for sampling related to potential PFAS contamination of groundwater and supply of alternative drinking water in New Hanover and three other counties downstream from Fayetteville.
Our other accrued liabilities decreased by $62 million (or 19%) to $263 million at June 30, 2022, compared with other accrued liabilities of $325 million at December 31, 2021. The decrease in our other accrued liabilities at June 30, 2022 was primarily attributable to payment of customer rebates during the first quarter of 2022, payment of income taxes in the second quarter of 2022, and a decrease in accrued current litigation following the payment of $25 million associated with our portion of the costs to enter into the Settlement Agreement, Limited Release, Waiver and Covenant Not to Sue reflecting Chemours, DuPont, Corteva, EID and State of Delaware’s agreement to settle and fully resolve claims alleged against the companies.
Credit Facilities and Notes
Refer to “Note 14 – Debt” to the Interim Consolidated Financial Statements and “Note 20 – Debt” to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2021 for a discussion of our credit facilities and notes.
Guarantor Financial Information
The following disclosures set forth summarized financial information and alternative disclosures in accordance with Rule 13-01 of Regulation S-X (“Rule 13-01”). These disclosures have been made in connection with certain subsidiaries' guarantees of the 4.000% senior unsecured notes due May 2026, which are denominated in euros and the 5.375% senior unsecured notes due May 2027 (collectively, the “Registered Notes”), which are registered under the Securities Act of 1933, as amended. Each series of the Registered Notes was issued by The Chemours Company (the “Parent Issuer”), and was fully and unconditionally guaranteed, jointly and severally, on a senior unsecured basis by the existing and future domestic subsidiaries of the Parent Issuer (together, the “Guarantor Subsidiaries”), subject to certain conditions as set forth in “Note 20 – Debt” to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2021. The assets, liabilities, and operations of the Guarantor Subsidiaries primarily consist of those attributable to The Chemours Company FC, LLC, our primary operating subsidiary in the United States, as well as the other U.S.-based operating subsidiaries as set forth in Exhibit 22 to this Quarterly Report on Form 10-Q. Each of the Guarantor Subsidiaries is 100% owned by the Company. None of our other subsidiaries, either direct or indirect, guarantee the Registered Notes (together, the “Non-Guarantor Subsidiaries”). Pursuant to the indentures governing the Registered Notes, the Guarantor Subsidiaries will be automatically released from those guarantees upon the occurrence of certain customary release provisions.
Our summarized financial information is presented on a combined basis, consisting of the Parent Issuer and Guarantor Subsidiaries (collectively, the “Obligor Group”), in accordance with the requirements under Rule 13-01, and is presented after the elimination of: (i) intercompany transactions and balances among the Parent Issuer and Guarantor Subsidiaries, and (ii) equity in earnings from and investments in the Non-Guarantor Subsidiaries.
(Dollars in millions)
| Six Months Ended June 30, 2022 | |
|---|---|
| Net sales | $2,397 |
| Gross profit | 530 |
| Income before income taxes | 246 |
| Net income | 213 |
| Net income attributable to Chemours | 213 |
(Dollars in millions)
| Assets | June 30, 2022 | December 31, 2021 |
|---|---|---|
| Current assets (1,2,3) | $1,909 | $1,554 |
| Long-term assets (4) | 3,394 | 3,720 |
| Liabilities | ||
| Current liabilities (2) | $1,530 | $1,504 |
| Long-term liabilities | 4,513 | 4,497 |
(1) Current assets includes $604 million and $525 million of cash and cash equivalents at June 30, 2022 and December 31, 2021, respectively.
(2) Current assets includes $555 million and $407 million of intercompany accounts receivable from the Non-Guarantor Subsidiaries at June 30, 2022 and December 31, 2021, respectively. Current liabilities includes $286 million and $328 million of intercompany accounts payable to the Non-Guarantor Subsidiaries at June 30, 2022 and December 31, 2021, respectively.
(3) As of June 30, 2022 and December 31, 2021, $217 million and $76 million of accounts receivable generated by the Obligor Group, respectively, remained outstanding with one of the Non-Guarantor Subsidiaries under the Securitization Facility.
(4) Long-term assets includes $463 million and $729 million of intercompany notes receivable from the Non-Guarantor Subsidiaries at June 30, 2022 and December 31, 2021, respectively.
There are no significant restrictions that may affect the ability of the Guarantor Subsidiaries in guaranteeing the Parent Issuer’s obligations under our debt financing arrangements. While the Non-Guarantor Subsidiaries do not guarantee the Parent Issuer’s obligations under our debt financing arrangements, we may, from time to time, repatriate post-2017 earnings from certain of these subsidiaries to meet our financing obligations, as well.
Supplier Financing
We maintain supply chain finance programs with several financial institutions. The programs allow our suppliers to sell their receivables to one of the participating financial institutions at the discretion of both parties on terms that are negotiated between the supplier and the respective financial institution. Our obligations to our suppliers, including the amounts due and scheduled payment dates, are not impacted by our suppliers’ decisions to sell their receivables under this program. At June 30, 2022 and December 31, 2021, the total amounts outstanding under these programs were $181 million and $153 million, respectively. Pursuant to their agreement with a financial institution, certain suppliers may elect to be paid early at their discretion. The available capacity under these programs can vary based on the number of investors and/or financial institutions participating in these programs at any point in time.
Off-Balance Sheet Arrangements
There have been no material changes to the off-balance sheet arrangement described in our MD&A and “Note 20 – Debt” to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2021.
Critical Accounting Policies and Estimates
Our significant accounting policies are described in our MD&A and “Note 3 – Summary of Significant Accounting Policies” to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2021. There have been no material changes to the critical accounting policies and estimates previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2021, except as described in “Note 2 – Recent Accounting Pronouncements” to the Interim Consolidated Financial Statements.
Recent Accounting Pronouncements
See “Note 2 – Recent Accounting Pronouncements” to the Interim Consolidated Financial Statements for a discussion about recent accounting pronouncements.
Environmental Matters
Consistent with our values and our Environment, Health, Safety, and Corporate Responsibility policy, we are committed to preventing releases to the environment at our manufacturing sites to keep our people and communities safe, and to be good stewards of the environment. We are also subject to environmental laws and regulations relating to the protection of the environment. We believe that, as a general matter, our policies, standards, and procedures are properly designed to prevent unreasonable risk of harm to people and the environment, and that our handling, manufacture, use, and disposal of hazardous substances are in accordance with applicable environmental laws and regulations.
Environmental Remediation
In large part, because of past operations, operations of predecessor companies, or past disposal practices, we, like many other similar companies, have clean-up responsibilities and associated remediation costs, and are subject to claims by other parties, including claims for matters that are liabilities of EID and its subsidiaries that we may be required to indemnify pursuant to the Separation-related agreements executed prior to our separation from EID on July 1, 2015 (the “Separation”).
Our environmental liabilities include estimated costs, including certain accruable costs associated with on-site capital projects. The accruable costs relate to a number of sites for which it is probable that environmental remediation will be required, whether or not subject to enforcement activities, as well as those obligations that result from environmental laws such as CERCLA, RCRA, and similar federal, state, local, and foreign laws. These laws may require certain investigative, remediation, and restoration activities at sites where we conduct or EID once conducted operations or at sites where our generated waste was disposed. At June 30, 2022 and December 31, 2021, our consolidated balance sheets include environmental remediation liabilities of $707 million and $562 million, respectively, relating to these matters, which, as discussed in further detail below, include $510 million and $359 million, respectively, for Fayetteville.
As remediation efforts progress, sites move from the investigation phase (“Investigation”) to the active clean-up phase (“Active Remediation”), and as construction is completed at Active Remediation sites, those sites move to the operation, maintenance, and monitoring (“OM&M”), or closure phase. As final clean-up activities for some significant sites are completed over the next several years, we expect our annual expenses related to these active sites to decline over time. The time frame for a site to go through all phases of remediation (Investigation and Active Remediation) may take about 15 to 20 years, followed by several years of OM&M activities. Remediation activities, including OM&M activities, vary substantially in duration and cost from site to site. These activities, and their associated costs, depend on the mix of unique site characteristics, evolving remediation technologies, and diverse regulatory requirements, as well as the presence or absence of other Potentially Responsible Parties (“PRPs”). In addition, for claims that we may be required to indemnify EID pursuant to the Separation-related agreements, we and EID may have limited available information for certain sites or are in the early stages of discussions with regulators. For these sites, there may be considerable variability between the clean-up activities that are currently being undertaken or planned and the ultimate actions that could be required. Therefore, considerable uncertainty exists with respect to environmental remediation costs, and, under adverse changes in circumstances, we currently estimate the potential liability may range up to approximately $720 million above the amount accrued at June 30, 2022. This estimate is not intended to reflect an assessment of our maximum potential liability. As noted above, the estimated liabilities are determined based on existing remediation laws and technologies and our planned remedial responses, which are derived from environmental studies, sampling, testing, and analyses. Inherent uncertainties exist in such evaluations, primarily due to unknown environmental conditions, changing governmental regulations regarding liability, and emerging remediation technologies. We will continue to evaluate as new or additional information becomes available in the determination of our environmental remediation liability.
In general, uncertainty is greatest and the range of potential liability is widest in the Investigation phase, narrowing over time as regulatory agencies approve site remedial plans. As a result, uncertainty is reduced, and sites ultimately move into OM&M, as needed. As more sites advance from Investigation to Active Remediation to OM&M or closure, the upper end of the range of potential liability is expected to decrease over time. Some remediation sites will achieve site closure and will require no further action to protect people and the environment and comply with laws and regulations. At certain sites, we expect that there will continue to be some level of remediation activity due to ongoing OM&M of remedial systems. In addition, portfolio changes, such as an acquisition or divestiture, or notification as a PRP for a multi-party Superfund site, could result in additional remediation activity and potentially additional accrual.
Significant Environmental Remediation Sites
While there are many remediation sites that contribute to our total accrued environmental remediation liabilities at June 30, 2022 and December 31, 2021, the following table sets forth the liabilities of the four sites that are deemed the most significant, together with the aggregate liabilities for all other sites.
(Dollars in millions)
| June 30, 2022 | December 31, 2021 | |
|---|---|---|
| Chambers Works, Deepwater, New Jersey | $30 | $27 |
| Fayetteville Works, Fayetteville, North Carolina | 510 | 359 |
| Pompton Lakes, New Jersey | 41 | 42 |
| USS Lead, East Chicago, Indiana | 19 | 24 |
| All other sites | 107 | 110 |
| Total environmental remediation | $707 | $562 |
The four sites listed above represent 85% of our total accrued environmental remediation liabilities at June 30, 2022 and December 31, 2021. For these four sites, we expect to spend, in the aggregate, $283 million over the next three years. For all other sites, we expect to spend $67 million over the next three years.
Chambers Works, Deepwater, New Jersey (“Chambers Works”)
The Chambers Works complex is located on the eastern shore of the Delaware River in Deepwater, Salem County, New Jersey. The site comprises the former Carneys Point Works in the northern area and the Chambers Works manufacturing area in the southern area. Site operations began in 1892 when the former Carneys Point smokeless gunpowder plant was constructed at the northern end of Carneys Point. Site operations began in the manufacturing area around 1914 and included the manufacture of dyes, aromatics, elastomers, chlorofluorocarbons, and tetraethyl lead. We continue to manufacture a variety of fluoropolymers and finished products at Chambers Works. In addition, two tenants operate processes at Chambers Works. As a result of over 100 years of continuous industrial activity, site soils and groundwater have been impacted by chemical releases.
In response to identified groundwater contamination, a groundwater interceptor well system (“IWS”) was installed in 1970, which was designed to contain contaminated groundwater and restrict off-site migration. Additional remediation is being completed under a federal RCRA Corrective Action permit. The site has been studied extensively over the years, and more than 25 remedial actions have been completed to date and engineering and institutional controls put in place to ensure protection of people and the environment. In 2017, a site perimeter sheet pile barrier intended to more efficiently contain groundwater was completed.
Remaining work beyond continued operation of the IWS and groundwater monitoring includes completion of various targeted studies on site and in adjacent water bodies to close investigation data gaps, as well as selection and implementation of final remedies under RCRA Corrective Action for various solid waste management units and areas of concern not yet addressed through interim measures. Discussions are ongoing with the U.S. Environmental Protection Agency (the “EPA”) and the New Jersey Department of Environmental Protection (the “NJ DEP”) relating to such remaining work as well as the scope of remedial programs and investigation relating to the Chambers Works site historic industrial activity as well as ongoing remedial programs.
Fayetteville Works, Fayetteville, North Carolina
Fayetteville is located southeast of the City of Fayetteville in Cumberland and Bladen counties, North Carolina. The facility encompasses approximately 2,200 acres, which were purchased by EID in 1970, and are bounded to the east by the Cape Fear River and to the west by North Carolina Highway 87. Currently, the Company manufactures fluorinated monomers, fluorinated vinyl ethers, NafionTM membranes and dispersions, and fluoropolymer processing aids at the site. A former manufacturing area, which was sold in 1992, produced nylon strapping and elastomeric tape. EID sold its Butacite® and SentryGlas® manufacturing units to Kuraray America, Inc. in September 2014. In July 2015, upon our Separation from EID, we became the owner of the Fayetteville land assets along with fluoromonomers, NafionTM membranes, and the related polymer processing aid manufacturing units. A polyvinyl fluoride resin manufacturing unit remained with EID.
Beginning in 1996, several stages of site investigation were conducted under oversight by the North Carolina Department of Environmental Quality (the “NC DEQ”), as required by the facility's hazardous waste permit. In addition, the site has voluntarily agreed to agency requests for additional investigations of the potential release of “PFAS” (perfluoroalkyl and polyfluoroalkyl substances) beginning with “PFOA” (collectively, perfluorooctanoic acids and its salts, including the ammonium salt) in 2006. As a result of detection of GenX in on-site groundwater wells during our investigations in 2017, the NC DEQ issued a Notice of Violation (“NOV”) in September 2017 alleging violations of North Carolina water quality statutes and requiring further response. Since that time, and in response to three additional NOVs issued by NC DEQ and pursuant to the Consent Order (as discussed below), we have worked cooperatively with the agency to investigate and address releases of PFAS to on-site and off-site groundwater and surface water.
As discussed in “Note 16 – Commitments and Contingent Liabilities” to the Interim Consolidated Financial Statements, we, along with NC DEQ and Cape Fear River Watch (“CFRW”), a non-profit organization, have filed a final Consent Order (“CO”) that comprehensively addressed various issues, NOVs, and court filings made by NC DEQ regarding Fayetteville and resolved litigations filed by NC DEQ and CFRW. In connection with the CO, a thermal oxidizer (“TO”) became fully operational at the site in December 2019 to reduce aerial PFAS emissions from Fayetteville. The CO requires us to provide permanent replacement drinking water supplies, via connection to public water supply, whole building filtration units and/or reverse osmosis units, to qualifying surrounding residents, businesses, schools, and public buildings with private drinking water wells.
In August 2020, we, along with NC DEQ and CFRW, reached agreement on the terms of an addendum to the CO (the “Addendum”). The Addendum establishes the procedure to implement specified remedial measures for reducing PFAS loadings from Fayetteville to the Cape Fear River, including construction of a barrier wall with groundwater extraction system to be completed by March 15, 2023. After a period of public comment, the Addendum was approved by the North Carolina Superior Court for Bladen County in October 2020 and establishes the procedure to implement specified remedial measures for reducing PFAS loadings from Fayetteville to the Cape Fear River, including construction of a barrier wall with a groundwater extraction system to be completed by March 15, 2023, or an extended date in accordance with the Addendum.
Further discussion related to Fayetteville is included under the heading “Fayetteville Works, Fayetteville, North Carolina” in “Note 16 – Commitments and Contingent Liabilities” to the Interim Consolidated Financial Statements.
Pompton Lakes, New Jersey
During the 20th century, blasting caps, fuses, and related materials were manufactured at Pompton Lakes, Passaic County, New Jersey. Operating activities at the site were ceased in the mid-1990s. The primary contaminants in the soil and sediments are lead and mercury. Groundwater contaminants include volatile organic compounds. Under the authority of EPA and NJ DEP, remedial actions at the site are focused on investigating and cleaning-up the area. Groundwater monitoring at the site is ongoing, and we have installed and continue to install vapor mitigation systems at residences within the groundwater plume. In addition, we are further assessing groundwater conditions. In September 2015, EPA issued a modification to the site’s RCRA permit that requires us to dredge mercury contamination from a 36-acre area of the lake and remove sediment from two other areas of the lake near the shoreline. The remediation activities commenced when permits and implementation plans were approved in May 2016, and work on the lake dredging project is now complete. In April 2019, we submitted a revised Corrective Measures Study (“CMS”) proposing actions to address on-site soils impacted from past operations that exceed applicable clean-up criteria. We received comments on the CMS from EPA and NJ DEP in March 2020, and we responded to their comments in June 2020 and continue to seek resolution with EPA.
U.S. Smelter and Lead Refinery, Inc., East Chicago, Indiana
The U.S. Smelter and Lead Refinery, Inc. (“USS Lead”) Superfund site is located in the Calumet neighborhood of East Chicago, Lake County, Indiana. The site includes the former USS Lead facility along with nearby commercial, municipal, and residential areas. The primary compounds of interest are lead and arsenic which may be found in soils within the impacted area. The EPA is directing and organizing remediation on this site, and we are one of a number of parties working cooperatively with EPA on the safe and timely completion of this work. EID’s former East Chicago manufacturing facility was located adjacent to the site, and EID assigned responsibility for the site to us in the Separation Agreement.
The USS Lead Superfund site was listed on the National Priorities List in 2009. To facilitate negotiations with PRPs, EPA divided the residential part of the USS Lead Superfund site into three zones, referred to as Zone 1, Zone 2, and Zone 3. The division into three zones resulted in Atlantic Richfield Co. (“Atlantic Richfield”) and EID entering into an agreement in 2014 with EPA and the State of Indiana to reimburse EPA’s costs to implement clean-up in Zone 1 and Zone 3. In March 2017, we and three other parties – Atlantic Richfield, EID, and the U.S. Metals Refining Co. (“U.S. Metals”) – entered into an administrative order on consent to reimburse EPA’s costs to clean-up a portion of Zone 2. In March 2018, EPA issued a Unilateral Administrative Order for the remainder of the Zone 2 work to five parties, including us, Atlantic Richfield, EID, U.S. Metals, and USS Lead Muller Group, and these parties entered into an interim allocation agreement to perform that work. As of the end of 2019, the required work in Zone 3 had been completed, and Zone 2 was nearly complete by the end of 2020. The determination of a final allocation for Zone 2 and/or the other Zones is ongoing, and additional PRPs may be identified.
The environmental accrual for USS Lead continues to include completion of the remaining obligations under the 2012 Record of Decision (“ROD”) and Statement of Work, which principally encompasses completion of Zone 1. The EPA released a proposed amendment to the 2012 ROD (the “ROD Amendment”) for a portion of Zone 1 in December 2018 (following its August 2018 Feasibility Study Addendum), with its recommended option based on future residential use. The EPA’s ROD Amendment for modified Zone 1 was released in March 2020, and selects as the preferred remedy one which requires a clean-up to residential standards based on the current applicable residential zoning. The ROD Amendment for modified Zone 1 also sets forth a selected contingent remedy which requires clean-up to commercial/industrial standards if the future land use becomes commercial/industrial. In November 2019, a Letter of Intent was executed by the City of East Chicago, Indiana and Industrial Development Advantage, LLC, relating to modified Zone 1 development, and EPA has indicated that it is “more likely” that future land use in this area will be commercial/industrial and not residential. We expect that our future costs for modified Zone 1 will be further contingent on the development of this area and implementation under the ROD Amendment, as well as any final allocation between PRPs. In 2021, we resolved the claims asserted by EPA related to past indirect costs associated with the 2012 ROD as amended, and the 2014 agreement entered into with EPA and the State of Indiana.
New Jersey Department of Environmental Protection Directives and Litigation
In March 2019, NJ DEP issued two Directives, one being a state-wide PFAS Directive, and filed four lawsuits against us and other defendants, including allegations relating to clean-up and removal costs at four sites including Chambers Works. In December 2021, a consolidated order was entered in the lawsuits granting, in part, and denying, in part a motion to dismiss or strike parts of the Second Amended Complaints. In January 2022, NJ DEP filed a motion for a preliminary injunction requiring EID and us to establish a remediation funding source (“RFS”) in the amount of $943 million for Chambers Works, the majority of which is for non-PFAS remediation items. Further discussion related to these matters is included in “Note 16 – Commitments and Contingent Liabilities” to the Interim Consolidated Financial Statements.
Climate Change
Central to our Corporate Responsibility Commitment (“CRC”) are our ten goals that we aim to achieve by 2030. These goals fall into three pillars: Inspired People, Shared Planet, and Evolved Portfolio. In April 2021, we announced an update to our climate goals to better align our climate commitment with the Paris Accord and set us on a path to achieve net zero greenhouse gas emissions from our operations by 2050. The Shared Planet pillar of our CRC underlines our commitment to deliver essential solutions responsibly, without causing harm to the Earth. With a focus on the responsible treatment of climate, water, and waste, our shared planet 2030 goals are comprised of the following:
- Reduce absolute operations Scope 1 and Scope 2 greenhouse gas (“GHG”) emissions by 60%;
- Reduce air and water process emissions of fluorinated organic chemicals by 99% or more; and,
- Reduce our landfill volume intensity by 70%.
As part of the Evolved Portfolio pillar of our CRC, we are reimagining our portfolio to offer solutions that are also safer, healthier, and more resilient for a world that demands more. We believe that climate change is an important global issue that presents both opportunities and challenges for our company, our partners, and our communities. Climate change matters for our company are likely to be driven by changes in physical climate parameters, regulations and/or public policy, and changes in technology and product demand. Our operations and business results are increasingly subject to evolving climate-related legislation and regulations, inclusive of restrictions on GHG emissions, cap and trade emissions trading systems, and taxes on GHG emissions, fuel, and energy, among other provisions. Such regulatory matters have led, and are expected to continue to lead, to subsequent developments in product technology and demand. This helps guide our investment decisions and drive growth in demand for low-carbon and energy-efficient products, manufacturing technologies, and services that facilitate adaptation to a changing climate. Our business segments conduct market trend impact assessments, continuously evaluate opportunities for existing and new products and are well-positioned to take advantage of opportunities that may arise from increased consumer demand for and/or legislation mandating or incentivizing the use of products and technologies necessary to achieve a low-carbon economy.
For example, global regulations driving the phase-down of HFCs, including the EU’s F-Gas Directive, the EU’s Mobile Air Conditioning Directive, and the recently enacted U.S. American Innovation and Manufacturing Act (“AIM”), promote the adoption and sale of our high performing Opteon™ products, which have lower global warming potential (“GWP”) and zero ozone-depletion footprint. Our Opteon™ portfolio has been developed to meet global regulations while maintaining or improving performance compared to the products they replace in refrigeration and cooling applications, such as food transportation, food and pharmaceutical/medical storage, food manufacturing and retail, automotive air conditioning, and residential and commercial building air conditioning. By the year 2025, we estimate that our low GWP products will eliminate an estimated 325 million tons of carbon dioxide equivalents on a global basis.
We are a proponent of the recently passed bipartisan AIM Act, that went into effect in 2022, and will begin the national phase-down of hydrofluorocarbons. In 2021, we announced the implementation of an improvement project to significantly reduce emissions of HFC-23 at our Louisville, Kentucky manufacturing site. The project includes the design, custom-build and installation of proprietary technology to capture at least 99% of HFC-23 process emissions from the site.
Our growth prospects in fluoropolymers are also enhanced by regulation driving the increasing demand for electric vehicles and high-performance, low-emission vehicles. Our fluoropolymers are critical to delivering high performance over a wide range of harsh operating conditions, enhancing passenger safety, improving emission controls, and better fuel economy, and enable vehicle electrification and the shift to hydrogen-powered vehicles. We expect the use of our fluoropolymers in vehicles to increase, driven by the automotive industry’s trends toward energy efficiency and clean energy due to evolving emissions performance regulations and increasing adoption of electric vehicles.
As an energy and emissions intensive company, our costs of complying with complex environmental laws, regulations, and enforcements, as well as internal and external voluntary programs, are significant and will continue to be significant for the foreseeable future. These laws, regulations, and enforcements may change and could become more stringent over time, which could result in significant additional compliance costs, increased costs of purchased energy or other raw materials, increased transportation costs, investments in, or restrictions on, our operations, installation or modification of GHG-emitting equipment, or additional costs associated with GHG emissions. Additionally, significant regional or national differences in approaches to the imposition of such regulations and restrictions could present competitive challenges in a global marketplace. Currently, most of our global operating facilities are required to monitor and report their GHG emissions but may or may not be subject to programs requiring trading or emission controls. The EU Emission Trading System applies to our operating sites in that region. Furthermore, U.S. political administration could lead to additional federal regulation with respect to GHG emissions limits and/or other legislation that could impact our operations. By tracking and taking action to reduce our GHG emissions footprint through energy efficiency programs and focused GHG management efforts, we can decrease the potential future impact of these regulatory matters.
PFOA
See our discussion under the heading “PFOA” in “Note 16 – Commitments and Contingent Liabilities” to the Interim Consolidated Financial Statements.
GenX
In June 2019, the Member States Committee of the European Chemicals Agency (“ECHA”) voted to list Hexafluoropropylene oxide dimer acid (“HFPO Dimer Acid”) as a Substance of Very High Concern. The vote was based on Article 57(f) – equivalent level of concern having probable serious effects to the environment. This identification does not impose immediate regulatory restriction or obligations, but may lead to a future authorization or restriction of the substance. On September 24, 2019, we filed an application with the EU Court of Justice for the annulment of the decision of ECHA to list HFPO Dimer Acid as a Substance of Very High Concern. In February 2022, the General Court dismissed the annulment action and we have appealed such decision.
PFAS
Refer to our discussion under the heading “PFAS” in “Note 16 – Commitments and Contingent Liabilities” to the Interim Consolidated Financial Statements.
In May 2020, ECHA announced that five Member States (Germany, the Netherlands, Norway, Sweden, and Denmark) launched a call for evidence to inform a PFAS restriction proposal. Companies producing or using PFAS, as well as selling mixture or products containing PFAS, were invited to provide input. This call for evidence closed July 31, 2020. Thousands of substances meet the definition of PFAS as outlined in the call for evidence. This very broad definition covers substances with a variety of physical and chemical properties, health and environmental profiles, uses, and benefits. We submitted information on the substances covered by the call for evidence to the Member State competent authority for Germany, which is the Federal Institute for Occupational Safety and Health (“BAuA”).
In May 2020, five European countries began an initiative to restrict the manufacture, placing on the market and use of PFAS in the EU. In this regulatory process, more than 4,000 substances, including F-gases and fluoropolymers are being considered as part of this broad regulatory action. On July 15, 2021, the countries submitted their restriction proposal, which informs ECHA of the intent to prepare a PFAS restriction dossier for fluorinated substances within a defined structural formula scope, including branched fluoroalkyl groups and substances containing ether linkages, fluoropolymers and side chain fluorinated polymers. The restriction dossier will include information on hazards and risks, available information on alternatives and an analysis of the risk management instrument for addressing the identified risks. The submitting countries indicate that they expect to submit the restriction dossier to ECHA in January 2023. As part of the preparation of the restriction dossier, stakeholders were requested to provide relevant information and, based on risk and socio-economic information, derogations from the proposed restriction may be proposed by the submitting countries. If a derogation is not proposed by the submitting countries, the relevant stakeholders may do so during a consultation process. The draft dossier will be reviewed by the ECHA committees Risk Assessment Committee (“RAC”) and Socio-economic Analysis Committees (“SEAC”) and proposals submitted to the EU Commission in 2023. The estimated entry into force of restrictions is 2025. The impacts of restrictions and regulatory measures could lead to material adverse effects on our results of operations, financial condition, and cash flows.
In October 2021, EPA released its PFAS Strategic Roadmap, identifying a comprehensive approach to addressing PFAS. The PFAS Strategic Roadmap sets timelines by which EPA plans to take specific actions through 2024, including establishing a national primary drinking water regulation for PFOA and perfluorooctanesulfonic acid (“PFOS”) and taking Effluent Limitations Guidelines actions to regulate PFAS discharges from industrial categories among other actions. As provided under its roadmap, EPA also released on the same day its National PFAS Testing Strategy, under which the agency will identify and select certain PFAS compounds for which it will require PFAS manufacturers to conduct testing pursuant to the Toxic Substances Control Act (“TSCA”) orders. EPA has indicated that we will receive orders for certain of such compounds, including seven of the testing orders that will be issued for PFAS compounds alleged to be associated with Fayetteville. In June 2022, EPA issued the first TSCA Section 4(a)(2) order under this program to five recipients, including us and EID, and we have met with the agency in July 2022 to discuss the order and responded to it.
Also in October 2021, EPA published a final toxicity assessment for GenX compounds that decreased the draft reference dose for GenX compounds based on EPA’s review of new studies and analyses. On March 18, 2022, we filed a petition to EPA requesting to withdraw and correct its toxicity assessment for GenX compounds, which was denied by EPA on June 14, 2022. The next day, on June 15, 2022, EPA released health advisories for four PFAS, including interim updated lifetime drinking water health advisories for PFOA and PFOS, and final health advisories for GenX compounds, including HFPO Dimer Acid, and another PFAS compound (PFBS). On July 13, 2022, we filed a Petition for Review of the GenX compounds health advisory. The environmental remediation liabilities and accrued litigation, as applicable, recorded for Fayetteville, Washington Works, Parkersburg, West Virginia and Chambers Works, Deepwater, New Jersey as of June 30, 2022 are based upon the existing Consent Orders, agreements and/or voluntary commitments with EPA, state and other local regulators and depending on the ultimate outcome of EPA’s actions, could require adjustment to meet any new drinking water standards. We continue to evaluate the impact of EPA’s June 15th health advisories and the PFAS Strategic Roadmap. It is reasonably possible that additional costs could be incurred in connection with EPA’s actions, however, we cannot estimate the potential impact or additional cost at this time, due in part to the uncertainties on EPA’s development of maximum contaminant levels for PFOA and PFOS and the implementation of the June 15th health advisories. Refer to our discussion under the heading “Fayetteville Works, Fayetteville, North Carolina” in “Note 16 – Commitments and Contingent Liabilities” to the Interim Consolidated Financial Statements.
Non-GAAP Financial Measures
We prepare our interim consolidated financial statements in accordance with generally accepted accounting principles in the U.S. (“GAAP”). To supplement our financial information presented in accordance with GAAP, we provide the following non-GAAP financial measures – Adjusted EBITDA, Adjusted Net Income, Adjusted Earnings per Share (“EPS”), Free Cash Flows (“FCF”), Return on Invested Capital (“ROIC”), and Net Leverage Ratio – in order to clarify and provide investors with a better understanding of our performance when analyzing changes in our underlying business between reporting periods and provide for greater transparency with respect to supplemental information used by management in its financial and operational decision-making. We utilize Adjusted EBITDA as the primary measure of segment profitability used by our CODM.
Adjusted EBITDA is defined as income (loss) before income taxes, excluding the following:
- interest expense, depreciation, and amortization;
- non-operating pension and other post-retirement employee benefit costs, which represents the components of net periodic pension (income) costs excluding the service cost component;
- exchange (gains) losses included in other income (expense), net;
- restructuring, asset-related, and other charges;
- (gains) losses on sales of assets and business; and,
- other items not considered indicative of our ongoing operational performance and expected to occur infrequently, including Qualified Spend reimbursable by DuPont and/or Corteva as part of our cost-sharing agreement under the terms of the MOU that were previously excluded from Adjusted EBITDA.
Adjusted Net Income is defined as our net income (loss), adjusted for items excluded from Adjusted EBITDA, except interest expense, depreciation, amortization, and certain provision for (benefit from) income tax amounts. Adjusted EPS is calculated by dividing Adjusted Net Income by the weighted-average number of our common shares outstanding. Diluted Adjusted EPS accounts for the dilutive impact of our stock-based compensation awards, which includes unvested restricted shares. FCF is defined as our cash flows provided by (used for) operating activities, less purchases of property, plant, and equipment as shown in our consolidated statements of cash flows. ROIC is defined as Adjusted Earnings before Interest and Taxes (“EBIT”), divided by the average of our invested capital, which amounts to our net debt, or debt less cash and cash equivalents, plus equity. Net Leverage Ratio is defined as our total debt principal, net, or our total debt principal outstanding less cash and cash equivalents, divided by Adjusted EBITDA.
We believe the presentation of these non-GAAP financial measures, when used in conjunction with GAAP financial measures, is a useful financial analysis tool that can assist investors in assessing our operating performance and underlying prospects. This analysis should not be considered in isolation or as a substitute for analysis of our results as reported under GAAP. In the future, we may incur expenses similar to those eliminated in this presentation. Our presentation of Adjusted EBITDA, Adjusted Net Income, Adjusted EPS, FCF, ROIC, and Net Leverage Ratio should not be construed as an inference that our future results will be unaffected by unusual or infrequently occurring items. The non-GAAP financial measures we use may be defined differently from measures with the same or similar names used by other companies. This analysis, as well as the other information provided in this Quarterly Report on Form 10-Q, should be read in conjunction with the Interim Consolidated Financial Statements and notes thereto included in this report, as well as the Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2021.
The following table sets forth a reconciliation of our net income (loss) attributable to Chemours to Adjusted Net Income, Adjusted EBITDA, and Adjusted EPS for the three and six months ended June 30, 2022 and 2021.
(Dollars in millions, except per share amounts)
| Three Months Ended June 30, 2022 | 2021 | Six Months Ended June 30, 2022 | 2021 | |
|---|---|---|---|---|
| Net income attributable to Chemours | $201 | $66 | $434 | $161 |
| Non-operating pension and other post-retirement employee benefit income | (2) | (2) | (3) | (5) |
| Exchange losses (gains), net | 3 | (3) | 3 | 5 |
| Restructuring, asset-related, and other charges (1) | — | 5 | 16 | — |
| Gain on sales of assets and businesses, net (2) | (26) | (2) | (27) | (2) |
| Natural disasters and catastrophic events (3) | — | 3 | — | 19 |
| Transaction costs | — | — | — | 5 |
| Qualified spend recovery (4) | (13) | — | (27) | — |
| Legal and environmental charges (5,6) | 170 | 195 | 178 | 208 |
| Adjustments made to income taxes (7) | (2) | (10) | (6) | (10) |
| Benefit from income taxes relating to reconciling items (8) | (29) | (47) | (28) | (58) |
| Adjusted Net Income | 302 | 205 | 540 | 323 |
| Interest expense, net | 40 | 47 | 82 | 97 |
| Depreciation and amortization | 72 | 79 | 146 | 163 |
| All remaining provision for income taxes | 61 | 35 | 110 | 51 |
| Adjusted EBITDA | $475 | $366 | $878 | $634 |
| Weighted-average number of common shares outstanding - basic | 156,224,802 | 166,168,550 | 158,051,092 | 165,912,089 |
| Dilutive effect of our employee compensation plans | 3,442,411 | 3,989,453 | 3,562,159 | 3,693,498 |
| Weighted-average number of common shares outstanding - diluted | 159,667,213 | 170,158,003 | 161,613,251 | 169,605,587 |
| Per share data | ||||
| Basic earnings per share of common stock | $1.29 | $0.40 | $2.75 | $0.97 |
| Diluted earnings per share of common stock | 1.26 | 0.39 | 2.69 | 0.95 |
| Adjusted basic earnings per share of common stock | 1.93 | 1.23 | 3.42 | 1.95 |
| Adjusted diluted earnings per share of common stock | 1.89 | 1.20 | 3.34 | 1.90 |
(1) In 2022, restructuring, asset-related, and other charges primarily includes asset charges and write-offs resulting from the conflict between Russia and Ukraine and our decision to suspend our business with Russian entities. In 2021, restructuring, asset-related, and other charges primarily includes a net $9 million gain resulting from contract termination with a third-party services provider at our previously owned Mining Solutions facility in Gomez Palacio, Durango, Mexico.
(2) Refer to “Note 6 – Other Income (Expense), Net” to the Interim Consolidated Financial Statements for further details.
(3) In 2021, natural disasters and catastrophic events pertains to the total cost of plant repairs and utility charges in excess of historical averages caused by Winter Storm Uri.
(4) Qualified spend recovery represents costs and expenses that were previously excluded from Adjusted EBITDA, reimbursable by DuPont and/or Corteva as part of our cost-sharing agreement under the terms of the MOU which is discussed in further detail in "Note 16 – Commitments and Contingent Liabilities" to the Interim Consolidated Financial Statements.
(5) Legal charges pertains to litigation settlements, PFOA drinking water treatment accruals, and other legal charges. For the three and six months ended June 30, 2021, legal charges include $25 million associated with our portion of the costs to enter into a Settlement Agreement, Limited Release, Waiver and Covenant Not to Sue reflecting Chemours, DuPont, Corteva, EID and the State of Delaware’s agreement to settle and fully resolve claims alleged against the companies. Refer to “Note 16 – Commitments and Contingent Liabilities” to the Interim Consolidated Financial Statements for further details.
(6) Environmental charges pertains to management’s assessment of estimated liabilities associated with certain non-recurring environmental remediation expenses at various sites. In 2022, environmental charges include $165 million primarily related to an update to the off-site drinking water programs at Fayetteville and changes in estimates related to the barrier wall constructions. In 2021, environmental charges include $169 million primarily related to the construction of the barrier wall, operation of the groundwater extraction and treatment system, and long-term enhancements to the old outfall treatment system. Refer to “Note 16 – Commitments and Contingent Liabilities” to the Interim Consolidated Financial Statements for further details.
(7) Includes the removal of certain discrete income tax impacts within our provision for income taxes, such as shortfalls and windfalls on our share-based payments, certain return-to-accrual adjustments, valuation allowance adjustments, unrealized gains and losses on foreign exchange rate changes, and other discrete income tax items.
(8) The income tax impacts included in this caption are determined using the applicable rates in the taxing jurisdictions in which income or expense occurred for each of the reconciling items and represent both current and deferred income tax expense or benefit based on the nature of the non-GAAP financial measure.
The following table sets forth a reconciliation of our cash flows provided by (used for) operating activities to FCF for the six months ended June 30, 2022 and 2021.
(Dollars in millions)
| Six Months Ended June 30, 2022 | 2021 | |
|---|---|---|
| Cash provided by operating activities | $293 | $295 |
| Less: Purchases of property, plant, and equipment (1) | (168) | (127) |
| Free Cash Flows | $125 | $168 |
(1) The six months ended June 30, 2021 includes $22 million related to construction-in-progress assets acquired in exchange for the termination of a contract with a third-party service provider at the Mining Solutions facility in Gomez Palacio, Durango, Mexico. In December 2021, the assets at the Mining Solutions facility in Gomez Palacio, Durango, Mexico were sold as part of the divestiture of our Mining Solutions Business.
The following table sets forth a reconciliation of Adjusted EBIT and average invested capital, and their nearest respective GAAP measures, to ROIC for the periods presented.
(Dollars in millions)
| Twelve Months Ended June 30, 2022 | 2021 | |
|---|---|---|
| Adjusted EBITDA (1) | $1,557 | $1,090 |
| Less: Depreciation and amortization (1) | (300) | (321) |
| Adjusted EBIT | $1,257 | $769 |
| As of June 30, | ||
| (Dollars in millions) | 2022 | 2021 |
| Total debt, net (2) | $3,680 | $3,989 |
| Total equity | 1,215 | 900 |
| Less: Cash and cash equivalents | (1,248) | (1,139) |
| Invested capital, net | $3,647 | $3,750 |
| Average invested capital (3) | $3,667 | $3,834 |
| Return on Invested Capital | 34% | 20% |
(1) Reconciliations of net income (loss) attributable to Chemours to Adjusted EBITDA are provided on a quarterly basis. Refer to the preceding table for the reconciliation of net income (loss) attributable to Chemours to Adjusted EBITDA for the six months ended June 30, 2022 and 2021.
(2) Total debt principal minus unamortized issue discounts of $5 million and $6 million and debt issuance costs of $25 million and $25 million at June 30, 2022 and 2021, respectively.
(3) Average invested capital is based on a five-quarter trailing average of invested capital, net.
The following table sets forth a reconciliation of our total debt principal, cash and cash equivalents, and Adjusted EBITDA to Net Leverage Ratio.
(Dollars in millions)
| As of June 30, 2022 | 2021 | |
|---|---|---|
| Total debt principal | $3,710 | $4,020 |
| Less: Cash and cash equivalents | (1,248) | (1,139) |
| Total debt principal, net | $2,462 | $2,881 |
| Twelve Months Ended June 30, | ||
| (Dollars in millions) | 2022 | 2021 |
| Adjusted EBITDA (1) | $1,557 | $1,090 |
| Net Leverage Ratio | 1.6x | 2.6x |
(1) Reconciliations of net income (loss) attributable to Chemours to Adjusted EBITDA are provided on a quarterly basis. Refer to the preceding table for the reconciliation of net income (loss) attributable to Chemours to Adjusted EBITDA for the six months ended June 30, 2022 and 2021.
Market risk
As filed, 6,690 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
We are exposed to changes in foreign currency exchange rates because of our global operations. As a result, we have assets, liabilities, and cash flows denominated in a variety of foreign currencies. We also have variable rate indebtedness, which subjects us to interest rate risk. Additionally, we are also exposed to changes in the prices of certain commodities that we use in production. Changes in these rates and commodity prices may have an impact on our future cash flows and earnings. We manage these risks through our normal operating and financing activities and, when deemed appropriate, through the use of derivative financial instruments. We do not enter into derivative financial instruments for trading or speculative purposes.
By using derivative financial instruments, we are subject to credit and market risk. The fair values of the derivative financial instruments are determined by using valuation models whose inputs are derived using market observable inputs, and reflect the asset or liability position as of the end of each reporting period. When the fair value of a derivative contract is positive, the counterparty owes us, thus creating a receivable risk for us. We are exposed to counterparty credit risk in the event of non-performance by counterparties to our derivative agreements. We minimize counterparty credit (or repayment) risk by entering into transactions with major financial institutions of investment grade credit ratings.
Our risk management programs and the underlying exposures are closely correlated, such that the potential loss in value for the risk management portfolio described above would be largely offset by the changes in the value of the underlying exposures. Refer to “Note 20 – Financial Instruments” to the Interim Consolidated Financial Statements for further information.
Foreign Currency Risks
We enter into foreign currency forward contracts to minimize the volatility in our earnings related to foreign exchange gains and losses resulting from remeasuring our monetary assets and liabilities that are denominated in non-functional currencies, and any gains and losses from the foreign currency forward contracts are intended to be offset by any gains or losses from the remeasurement of the underlying monetary assets and liabilities. These derivatives are stand-alone and, except as described below, have not been designated as a hedge. At June 30, 2022, we had 13 foreign currency forward contracts outstanding with an aggregate gross notional U.S. dollar equivalent of $297 million, the fair value of which amounted to $1 million. At December 31, 2021, we had 12 foreign currency forward contracts outstanding with an aggregate gross notional U.S. dollar equivalent of $254 million, the fair value of which amounted to less than negative $1 million. We recognized a net gain of $5 million and a net loss of $1 million for the three and six months ended June 30, 2022, respectively, and a net gain of $9 million and a net loss of $11 million for the three and six months ended June 30, 2021, respectively, within other income (expense), net related to our non-designated foreign currency forward contracts.
We enter into certain qualifying foreign currency forward contracts under a cash flow hedge program to mitigate the risks associated with fluctuations in the euro against the U.S. dollar for forecasted U.S. dollar-denominated inventory purchases in certain of our international subsidiaries that use the euro as their functional currency. At June 30, 2022, we had 185 foreign currency forward contracts outstanding under our cash flow hedge program with an aggregate notional U.S. dollar equivalent of $220 million, the fair value of which amounted to $8 million. At December 31, 2021, we had 175 foreign currency forward contracts outstanding under our cash flow hedge program with an aggregate notional U.S. dollar equivalent of $195 million, the fair value of which amounted to $5 million. We recognized pre-tax gains of $6 million and $11 million for the three and six months ended June 30, 2022, respectively, and a pre-tax loss of $1 million and a pre-tax gain of $3 million for the three and six months ended June 30, 2021, respectively, within accumulated other comprehensive loss. For the three and six months ended June 30, 2022, $3 million and $6 million of gain was reclassified to the cost of goods sold from accumulated other comprehensive loss, respectively. For the three and six months ended June 30, 2021, $1 million and $3 million of loss was reclassified to the cost of goods sold from accumulated other comprehensive loss, respectively.
We designated our euro-denominated debt as a hedge of our net investment in certain of our international subsidiaries that use the euro as their functional currency in order to reduce the volatility in stockholders’ equity caused by changes in foreign currency exchange rates of the euro with respect to the U.S. dollar. We recognized pre-tax gains of $32 million and $58 million for the three and six months ended June 30, 2022, respectively, and a pre-tax loss of $13 million and a pre-tax gain of $24 million for the three and six months ended June 30, 2021, respectively, on our net investment hedge within accumulated other comprehensive loss.
Interest Rate Risk
We entered into interest rate swaps to mitigate the volatility in our cash payments for interest due to fluctuations in the London Interbank Offered Rate (“LIBOR”), as is applicable to the portion of our senior secured term loan facility denominated in U.S. dollars. At June 30, 2022, we had three interest rate swaps outstanding under our cash flow hedge program with an aggregate notional U.S. dollar equivalent of $400 million, the fair value of which amounted to $7 million. At December 31, 2021, we had three interest rate swaps outstanding under our cash flow hedge program with an aggregate notional U.S. dollar equivalent of $400 million, the fair value of which amounted to less than $1 million. We recognized pre-tax gains of $3 million and $7 million for the three and six months ended June 30, 2022, respectively, and a pre-tax loss of less than $1 million and a pre-tax gain of less than $1 million for the three and six months ended June 30, 2021, respectively, within accumulated other comprehensive loss. For the three and six months ended June 30, 2022, $1 million of gain and less than $1 million of loss was reclassified to interest expense, net from accumulated other comprehensive losses, respectively. For the three and six months ended June 30, 2021, $1 million of loss was reclassified to interest expense, net from accumulated other comprehensive loss.
Controls and procedures
As filed, 1,404 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Disclosure Controls and Procedures
We maintain disclosure controls and procedures designed to provide reasonable assurance that the information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 (“Exchange Act”) is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the U.S. Securities and Exchange Commission (“SEC”). These controls and procedures also provide reasonable assurance that information required to be disclosed in such reports is accumulated and communicated to management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), to allow timely decisions regarding required disclosures.
As of June 30, 2022, our CEO and CFO, together with management, conducted an evaluation of the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) under the Exchange Act. Based on that evaluation, the CEO and CFO have concluded that these disclosure controls and procedures are effective at the reasonable assurance level.
Changes in Internal Control over Financial Reporting
There have been no changes in our internal control over financial reporting that occurred during the quarter ended June 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 137 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2021.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-04-01 to 2022-06-30 | $1.92bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2022-01-01 to 2022-06-30 | $3.68bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-04-01 to 2022-06-30 | $1.42bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2022-01-01 to 2022-06-30 | $2.70bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2022-04-01 to 2022-06-30 | $497.0m | us-gaap:GrossProfit |
| Gross profit | 6 months2022-01-01 to 2022-06-30 | $982.0m | us-gaap:GrossProfit |
| Research and development | 3 months2022-04-01 to 2022-06-30 | $25.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2022-01-01 to 2022-06-30 | $55.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2022-04-01 to 2022-06-30 | $254.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2022-01-01 to 2022-06-30 | $395.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months2022-04-01 to 2022-06-30 | $40.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2022-01-01 to 2022-06-30 | $82.0m | us-gaap:InterestExpense |
| Income tax | 3 months2022-04-01 to 2022-06-30 | $30.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2022-01-01 to 2022-06-30 | $76.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-04-01 to 2022-06-30 | $201.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2022-01-01 to 2022-06-30 | $434.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-04-01 to 2022-06-30 | $1.26 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2022-01-01 to 2022-06-30 | $2.69 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-04-01 to 2022-06-30 | $1.29 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2022-01-01 to 2022-06-30 | $2.75 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-04-01 to 2022-06-30 | 159,667,213 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2022-01-01 to 2022-06-30 | 161,613,251 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2022-01-01 to 2022-06-30 | $293.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2022-01-01 to 2022-06-30 | $168.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2022-01-01 to 2022-06-30 | $78.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2022-01-01 to 2022-06-30 | $272.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-06-30 | $1.25bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-06-30 | $3.61bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-06-30 | $7.73bn | us-gaap:Assets |
| Current liabilities | At period end2022-06-30 | $1.89bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-06-30 | $6.51bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-06-30 | $3.66bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2022-06-30 | $24.0m | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2022-06-30 | $1.21bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001564590-22-027142. Last ingested by Listed: Nov 5, 2026, 19:57 ET. Listed shows no prices and gives no investment advice.